PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate (IMAGE)

The Hong Kong Polytechnic University

PolyU develops Tumour Heterogeneity Index to precisely identify breast cancer patient drug response, achieving a 56% pathological complete response rate

Caption

Prof. Cai Jing said that using THI to identify patients most likely to benefit from specific treatments could not only improve overall treatment outcomes but also spare patients unnecessary side effects from treatments with limited effectiveness.

Credit

polyu

Usage Restrictions

nil

License

Original content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.